Nearly one-quarter of Medicare's top-prescribing physicians received consulting fees or other financial perks from manufacturers of the drugs they prescribed in 2013, renewing nagging questions about conflicts of interest in medical decisionmaking.
Medicare and Medicaid have dramatically altered American life and all facets of the U.S. healthcare industry. The programs are poised to change significantly in the years ahead. Explore our special coverage marking their 50th anniversary.
A list of the largest publicly traded pharmaceutical companies, ranked by 2014 revenue reported to the U.S. Securities and Exchange Commission and other sources. Source: Modern Healthcare reporting. Published May 25, 2015. p. 50
President Barack Obama will speak at the Catholic Health Association's 2015 annual membership assembly in June, the association announced Monday. His speech will focus on the future of healthcare and the Affordable Care Act.
The health insurance industry has been abuzz the past few weeks with speculation that a big merger is near. Aetna, Anthem, Cigna Corp. and Humana have all been at its epicenter. But do the rumblings really predict a seismic deal?
A U.S. Supreme Court decision Tuesday won't extend the statute of limitations in fraud lawsuits, as many in the healthcare industry had feared it might. But the ruling could make it easier, in some cases, for whistle-blowers to file fraud lawsuits over issues already brought to court.
In Pittsburgh's fiercely competitive market, the UPMC health system announced voluntary buyouts to reduce labor costs.
The CMS wants to launch a system to track enforcement actions against Medicare providers over questionable claims. Fraud costs the federal government an estimated $60 billion to $90 billion annually.
World health leaders adopted a plan Monday addressing the rising global problem of antimicrobial resistance, as well as efforts toward improving access to vaccines for developing countries.